1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: PDL-195-301, MSKCC-00029, UCLA-9910050, NCI-G00-1819, NCT00006045
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor:
Protocol IDs: MSKCC-93111, NCI-V94-0350
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 12
Sponsor:
Protocol IDs: MSKCC-93117, NCI-V94-0359
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor: NCI
Protocol IDs: MSKCC-94088A3, NCI-H94-0571, NCT00002609
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 16
Sponsor:
Protocol IDs: MSKCC-95009, NCI-V95-0631
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-96044, NCI-V96-0941, NCT00002800
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-97103, PDL-3-201, NCI-G97-1367
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068076, UCLA-9910096, PDL-195-302, NCI-G00-1823, NCT00006084
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000068600, MSKCC-00072, NCI-H01-0073, NCT00016159
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor:
Protocol IDs: MSKCC-93083, NCI-V93-0315
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG033-0003, NCT00528333
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: physiologic 50 and under
Sponsor: Other
Protocol IDs: MSKCC-93132, NCI-V94-0358
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 12 and over
Sponsor: Other
Protocol IDs: MSKCC-95043, NCI-V95-0709
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MSKCC-96003A1, NCI-T95-0026H, T95-0026
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: MSKCC-96010, NCI-H96-1100, NCT00002890
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-96014A1, NCI-H96-1101
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 12
Sponsor:
Protocol IDs: MSKCC-92088, NCI-V92-0130
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DM98-342, NCT00038051
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG033-0001, NCT00283114
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG033-0002, NCT00502112
|
Mobile | Español
